A dozen pharmaceutical companies are preparing to produce a pandemic vaccine to protect against swine flu, which was first identified in Mexico last month.

The World Health Organisation on Monday said that leading vaccine producers including Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A (H1N1) virus.